- Category: National Policy Reports
Lithium-ion batteries for electric vehicles have become one of the specialties of Polish exports. They mainly go to other EU member states. But in order to maintain the position of the EU leader and, at the same time, successfully compete with Asian producers, Poland must not only further develop its production capacity, but also produce lithium-ion batteries with a lower carbon footprint.
- Category: Articles
The process of drafting of national recovery plans under a difficult time constraints seems to be a handful for all of the Visegrad countries. The stakeholder involvement, streamlining their requests and transparency pose particular problems.
- Category: Articles
Listen to the podcast from the online event - Winners and Losers of the pandemic - the Visegrad outlook.
- Category: Articles
Visegrad governments should use the opportunity of the crisis for structural changes and reforms in the labour market, education and healthcare. They should also look beyond the GDP and embrace green transformation.
Support
Partners
RSS - EURACTIV
-
European Medicines Agency makes recommendations to improve supply of critical medicines
As EU health ministers gather in Brussels on 23-24 April to discuss access to critical medicines and formally launch the Critical Medicines Alliance, the European Medicines Agency (EMA) has published its own recommendations to address vulnerabilities in the production and delivery of medicines on the EU’s critical list.
-
Paris Olympic Village getting climate fit for 2050 [Advocacy Lab Content]
Paris is getting climate fit for July's Olympic Games. The Olympic Village is vaunted as an experimental model showcasing adaptations France needs for 2050's climate shift, and Olympic athletes could be modelling future living for the rest of Europe.
-
Polish patient education needed to boost clinical trial success [Advocacy Lab Content]
Poland's clinical trials give access to innovative therapies for over 25,000 patients, but a new Medical Research Agency survey reports half of Poles lack any real understanding of clinical trials, hindering long-term success.